Regulations.gov document
Agency Response Letter from FDA CVM to Aurora Pharmaceutical, Inc.
Other · FDA-2023-P-2347 · posted Aug 31, 2023
Key facts
| Document ID | FDA-2023-P-2347-0004 |
|---|---|
| Title | Agency Response Letter from FDA CVM to Aurora Pharmaceutical, Inc. |
| Document type | Other |
| Subtype | Agency Response |
| Agency | FDA |
| Docket | FDA-2023-P-2347 |
| Posted | Aug 31, 2023 |
| Comment period opens | Aug 31, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: